Upper and small bowel Crohn's disease in Brazilian children: Phenotypic characteristic and surgical risk

Read full text Summarise with VIRAT
Authors: Jane Oba, Carlos Walter Sobrado-Junior, Elizete Aparecida Lomazi, Mariana Deboni, Michela Cynthia da Rocha Marmo, Vanessa Adriana Scheeffer, Silvio da Rocha Carvalho, Adérson Omar Mourão Cintra Damião, Matheus Freitas Cardoso de Azevedo, Carlos Frederico Sparapan Marques, Eytan Wine, Artur Figueiredo Delgado
+1 more Clóvis A. Silva
Cited by: 0
References: 30

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVES: Upper and small bowel Crohn's disease (U-SBCD) represents a clinically aggressive phenotype with high complication rates yet remains diagnostically challenging. In low- and middle-income countries (LMICs), limited inflammatory bowel disease (IBD) awareness contributes to diagnostic delays, but their impact on U-SBCD outcomes remains poorly characterized. We aimed to characterize clinical features, management patterns, and surgical outcomes of pediatric U-SBCD in Brazil, establishing IBD baseline for future regional comparisons in LMIC setting. METHODS: This multicenter retrospective study analyzed 124 pediatric Crohn's disease (CD) patients (diagnosed < 18 years) from six Brazilian centers according to revised PORTO-European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) criteria. Patients with U-SBCD (Paris L4a/L4b, n = 39) were compared to non-SBCD (L1/L2/L3). Univariate and multivariable analyses assessed demographics, diagnostic delay, disease behavior, growth impairment, and therapeutic outcomes over 18 months follow-up. The population comprised predominantly African-Brazilian admixture. RESULTS: U-SBCD patients presented at older age (median 14 vs. 12 years; p = 0.001) with greater height impairment (p = 0.010) and lower body mass index (BMI)/age z-scores (-1.14 vs. -0.44; p = 0.029). Severe weight loss (z-score < -2) conferred 8.3-fold increased U-SBCD odds (95% confidence interval [CI]: 2.17-31.66; p = 0.002). Each year of diagnostic delay increased U-SBCD odds by 22% (95% CI: 1.06-1.39; p = 0.004). U-SBCD patients required more biologic therapy (97% vs. 75%; p = 0.003) with higher treatment escalation rates (31.6% vs. 21.2%; p = 0.004). Multivariate analysis confirmed U-SBCD as an independent three-fold predictor of surgery (OR 3.02; 95% CI: 1.02-8.94; p = 0.046). A 9-year-old girl with U-SBCD died perioperatively. Psychiatric symptoms affected 30% of both groups. CONCLUSION: In LMIC settings, strengthening medical education is essential to improve early recognition of U-SBCD and prevent progression to irreversible complications. Notably, the phenotypic pattern observed in our study more closely resembled that reported in Asian pediatric patients than Caucasian cohorts.

Fields of Study & Subjects

Inflammatory Bowel Disease Gastrointestinal disorders and treatments Diagnosis and treatment of tuberculosis

Publication details

Journal / source
Journal of Pediatric Gastroenterology and Nutrition
Volume
83
Issue
1
Pages
87–95
Publication date
26 March 2026
Language
EN